Skip to content
BIO Events
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025
The year in biotech M&A activity got off to a promising start at JPM Week with announcements of some multi-billion-dollar deals. The flurry of networking ...
Read More
Latest News
LATEST STORIES
Health
FDA approves JOURNAVX, Vertex’s non-addictive pain treatment
Pictured: JOURNAVX bottle and tablet (Photo: Business Wire) The U.S. Food and Drug Administration (FDA) on Jan. 30 approved Vertex Pharmaceuticals’ JOURNAVX™ (suzetrigine) for treatment ...
BIO's View
What BIO’s watching in the new Congress
Reforms to prevent middlemen from driving up drug prices and legislation encouraging the development of oral medications and rare disease treatments were called top priorities ...
Agriculture
Farm to Fly Act reintroduced in Senate would give SAF wings
Legislation introduced last year to ease widespread commercialization of sustainable aviation fuel (SAF) was reintroduced Jan. 16 as one of the early measures proposed for ...
WHAT YOU MISSED AT THE LATEST BIO EVENTS
Multi-billion-dollar deals at JPM Week augur a busy BIO CEO 2025
The year in biotech M&A activity got off to a promising start at JPM Week with announcements of some multi-billion-dollar deals. The flurry of networking ...
Read More
Harms of PBMs explained in BIO Patient Advocacy Coffee Chat
Pharmacy benefit managers (PBMs) create unnecessary barriers between patients and the medicine they need, experts explained during a Nov. 25 virtual “Patient Advocacy Coffee Chat” ...
Read More